NCT05687344View on ClinicalTrials.gov

Intensive Postpartum Antihypertensive Treatment

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Hypertensive Disorder of Pregnancy
Interventions
DRUG

Nifedipine ER

Postpartum BP treatment to \<140/90 mmHg

Trial Locations (1)

53226

Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT05687344 - Intensive Postpartum Antihypertensive Treatment | Biotech Hunter | Biotech Hunter